| UniProt ID | BATF3_HUMAN | |
|---|---|---|
| UniProt AC | Q9NR55 | |
| Protein Name | Basic leucine zipper transcriptional factor ATF-like 3 | |
| Gene Name | BATF3 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 127 | |
| Subcellular Localization | Nucleus . | |
| Protein Description | AP-1 family transcription factor that controls the differentiation of CD8(+) thymic conventional dendritic cells in the immune system. Required for development of CD8-alpha(+) classical dendritic cells (cDCs) and related CD103(+) dendritic cells that cross-present antigens to CD8 T-cells and produce interleukin-12 (IL12) in response to pathogens (By similarity). Acts via the formation of a heterodimer with JUN family proteins that recognizes and binds DNA sequence 5'-TGA[CG]TCA-3' and regulates expression of target genes.. | |
| Protein Sequence | MSQGLPAAGSVLQRSVAAPGNQPQPQPQQQSPEDDDRKVRRREKNRVAAQRSRKKQTQKADKLHEEYESLEQENTMLRREIGKLTEELKHLTEALKEHEKMCPLLLCPMNFVPVPPRPDPVAGCLPR | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Phosphorylation | ------MSQGLPAAG ------CCCCCCCCH | 32.71 | 20164059 | |
| 10 | Phosphorylation | QGLPAAGSVLQRSVA CCCCCCHHHHHHHCC | 18.22 | 29457462 | |
| 31 | Phosphorylation | QPQPQQQSPEDDDRK CCCCCCCCCCCCHHH | 26.39 | 23401153 | |
| 57 | Phosphorylation | QRSRKKQTQKADKLH HHHHHHHHHHHHHHH | 40.70 | 25690035 | |
| 67 | Phosphorylation | ADKLHEEYESLEQEN HHHHHHHHHHHHHHH | 14.08 | 26552605 | |
| 69 | Phosphorylation | KLHEEYESLEQENTM HHHHHHHHHHHHHHH | 35.98 | 26552605 | |
| 75 | Phosphorylation | ESLEQENTMLRREIG HHHHHHHHHHHHHHH | 19.48 | 26552605 | |
| 83 | Ubiquitination | MLRREIGKLTEELKH HHHHHHHHHHHHHHH | 58.87 | 29967540 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of BATF3_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of BATF3_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of BATF3_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-31, AND MASSSPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-31, AND MASSSPECTROMETRY. | |